265 related articles for article (PubMed ID: 22728597)
21. Proteolytic activity of non-albicans Candida and Candida albicans in oral cancer patients.
Nawaz A; Mäkinen A; Pärnänen P; Meurman JH
New Microbiol; 2018 Oct; 41(4):296-301. PubMed ID: 30311625
[TBL] [Abstract][Full Text] [Related]
22. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.
Junqueira JC; Fuchs BB; Muhammed M; Coleman JJ; Suleiman JM; Vilela SF; Costa AC; Rasteiro VM; Jorge AO; Mylonakis E
BMC Microbiol; 2011 Nov; 11():247. PubMed ID: 22053894
[TBL] [Abstract][Full Text] [Related]
23. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.
Stokes C; Moran GP; Spiering MJ; Cole GT; Coleman DC; Sullivan DJ
Fungal Genet Biol; 2007 Sep; 44(9):920-31. PubMed ID: 17251042
[TBL] [Abstract][Full Text] [Related]
24. White-to-opaque switching is involved in the phospholipase B production of Candida dubliniensis on Price's egg yolk agar.
Fukui K; Nakamura K; Kuwashima H; Majima T
Odontology; 2019 Apr; 107(2):174-185. PubMed ID: 30083973
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic activity profile of a Brazilian culture collection of Candida albicans isolated from diabetics and non-diabetics with oral candidiasis.
Sanitá PV; Zago CE; Pavarina AC; Jorge JH; Machado AL; Vergani CE
Mycoses; 2014 Jun; 57(6):351-7. PubMed ID: 24329754
[TBL] [Abstract][Full Text] [Related]
26. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
27. Candida dubliniensis: phylogeny and putative virulence factors.
D Gilfillan G; Derek J S; Parkinson T; Coleman DC; Gow NAR
Microbiology (Reading); 1998 Apr; 144 ( Pt 4)():829-838. PubMed ID: 9579058
[TBL] [Abstract][Full Text] [Related]
28. Discovery of the gray phenotype and white-gray-opaque tristable phenotypic transitions in Candida dubliniensis.
Yue H; Hu J; Guan G; Tao L; Du H; Li H; Huang G
Virulence; 2016 Apr; 7(3):230-42. PubMed ID: 26714067
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis.
Moran GP; MacCallum DM; Spiering MJ; Coleman DC; Sullivan DJ
Mol Microbiol; 2007 Nov; 66(4):915-29. PubMed ID: 17927699
[TBL] [Abstract][Full Text] [Related]
30. Differences in extracellular enzymatic activity between Candida dubliniensis and Candida albicans isolates.
Vidotto V; Pontón J; Aoki S; Quindós G; Mantoan B; Pugliese A; Ito-Kuwa S; Nakamura K
Rev Iberoam Micol; 2004 Jun; 21(2):70-4. PubMed ID: 15538830
[TBL] [Abstract][Full Text] [Related]
31. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals.
Koga-Ito CY; Lyon JP; Vidotto V; de Resende MA
Mycopathologia; 2006 Apr; 161(4):219-23. PubMed ID: 16552484
[TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
[TBL] [Abstract][Full Text] [Related]
33. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
[TBL] [Abstract][Full Text] [Related]
34. Enzymatic and hemolytic activities of Candida dubliniensis strains.
Linares CE; de Loreto ES; Silveira CP; Pozzatti P; Scheid LA; Santurio JM; Alves SH
Rev Inst Med Trop Sao Paulo; 2007; 49(4):203-6. PubMed ID: 17823746
[TBL] [Abstract][Full Text] [Related]
35. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial photodynamic therapy in rat experimental candidiasis: evaluation of pathogenicity factors of Candida albicans.
Martins Jda S; Junqueira JC; Faria RL; Santiago NF; Rossoni RD; Colombo CE; Jorge AO
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):71-7. PubMed ID: 21176823
[TBL] [Abstract][Full Text] [Related]
37. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis.
Chen YL; Brand A; Morrison EL; Silao FG; Bigol UG; Malbas FF; Nett JE; Andes DR; Solis NV; Filler SG; Averette A; Heitman J
Eukaryot Cell; 2011 Jun; 10(6):803-19. PubMed ID: 21531874
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of human saliva on experimental murine oral candidiasis.
Kamagata-Kiyoura Y; Abe S; Yamaguchi H; Nitta T
J Infect Chemother; 2004 Aug; 10(4):253-5. PubMed ID: 15365870
[TBL] [Abstract][Full Text] [Related]
39. Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals.
Pinto E; Ribeiro IC; Ferreira NJ; Fortes CE; Fonseca PA; Figueiral MH
J Oral Pathol Med; 2008 Nov; 37(10):587-92. PubMed ID: 18764856
[TBL] [Abstract][Full Text] [Related]
40. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals.
Schorling SR; Kortinga HC; Froschb M; Mühlschlegel FA
Crit Rev Microbiol; 2000; 26(1):59-68. PubMed ID: 10782340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
